Accessibility Menu

60 Degrees Pharmaceuticals(NASDAQ) SXTPW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-95%
5 YearN/A
1 Year-59%
1 Month+20%
$0.03
-15.53%
-0.01Today
60 Degrees Pharmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 0.042026-08-31
60 Degrees Pharmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+45.06%USD 0.032026-08-24
1 month+19.93%USD 0.032026-07-31
3 month-4.92%USD 0.042026-06-02
Year to date-41.56%USD 0.062025-12-31
1 year-59.4%USD 0.092025-08-29
3 year-92.29%USD 0.482023-09-01
Since inception-95.47%USD 0.812023-07-12

60 Degrees Pharmaceuticals Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.11M

Net Income (TTM)

-$8.11M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

1,028

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.02 - $0.15

Estimated Earnings Date

N/A

SXTPW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Industry

Pharmaceuticals

Sector

Health Care

SXTPW Financials

Key Financial Metrics (TTM)

Gross Margin

19.42%

Operating Margin

-774.90%

Net Income Margin

-730.22%

Return on Equity

-216.35%

Return on Capital

-229.58%

Return on Assets

-189.43%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1.03K

Avg. Volume

3.26K

Financials (TTM)

Gross Profit

$215.79K

Operating Income

-$8.61M

EBITDA

-$741.61K

Operating Cash Flow

$1.14M

Capital Expenditure

$24.52K

Free Cash Flow

$1.17M

Cash & ST Invst.

$1.02M

Total Debt

$0.00

60 Degrees Pharmaceuticals Performance Analysis

60 Degrees Pharmaceuticals sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30333.6%
Q42025-12-31-30.7%
Q12026-03-31-46.6%
Q22026-06-3028.3%
60 Degrees Pharmaceuticals sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3047.2%
Q42025-12-31-1151.5%
Q12026-03-3184.5%
Q22026-06-3029.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$207.90K

+106.0%

Gross Profit

$56.80K

+11.6%

Gross Margin

27.32%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$2.27M

-30.6%

EBITDA

-$2.27M

-41.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.02M

-48.0%

Total Debt

$0.00

N/A

Accounts Receivable

$567.04K

+92.2%

Inventory

$877.95K

+9.8%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.89%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$2.77M

+72.9%

Operating Cash Flow

$2.74M

+71.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,634.27-0.01%
^DJIDJI
$52,797.46-0.01%
^IXICNASDAQ
$26,099.39-0.01%
BTCBitcoin
$77,103.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$14.06+0.06%
NVDANvidia
$217.44-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.33-0.06%
INTCIntel
$88.97-0.01%

Questions About SXTPW

What is the current price of 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals is trading at $0.03 per share.

What is the 52-week range for 60 Degrees Pharmaceuticals?

Over the past 52 weeks, 60 Degrees Pharmaceuticals has traded between $0.02 and $0.15.

How much debt does 60 Degrees Pharmaceuticals have?

60 Degrees Pharmaceuticals total debt is unavailable.

How much cash does 60 Degrees Pharmaceuticals have on hand?

60 Degrees Pharmaceuticals does not have cash on hand data available.

What is 60 Degrees Pharmaceuticals’s dividend yield?

60 Degrees Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services